Synapse - Works

Results (351)

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): Primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

Journal Article

Smit, E. F.; Felip, E.; Uprety, D.; Nagasaka, M.; Nakagawa, K.; Paz-Ares Rodríguez, L.; Pacheco, J. M.; Li, B. T.; Planchard, D.; Baik, C.; more...
Lancet Oncology (2024)

Fulltext@MSK | Save

Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer

Review

Browne, I. M.; André, F.; Chandarlapaty, S.; Carey, L. A.; Turner, N. C.
Lancet Oncology (2024)

Fulltext@MSK | Save

Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): A phase 3, multicentre, open-label trial

Journal Article

Mahadeo, K. M.; Baiocchi, R.; Beitinjaneh, A.; Chaganti, S.; Choquet, S.; Dierickx, D.; Dinavahi, R.; Duan, X.; Gamelin, L.; Ghobadi, A.; more...
Lancet Oncology (2024)

Fulltext@MSK | Save

Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): An interim analysis of the multicentre, double-blind, randomised phase 3 study

Journal Article

Shitara, K.; Rha, S. Y.; Wyrwicz, L. S.; Oshima, T.; Karaseva, N.; Osipov, M.; Yasui, H.; Yabusaki, H.; Afanasyev, S.; Park, Y. K.; more...
Lancet Oncology (2024)

Fulltext@MSK | Save

Global cancer surgery: Pragmatic solutions to improve cancer surgery outcomes worldwide

Review

Are, C.; Murthy, S. S.; Sullivan, R.; Schissel, M.; Chowdhury, S.; Alatise, O.; Anaya, D.; Are, M.; Balch, C.; Bartlett, D.; more...
Lancet Oncology (2023)

Fulltext@MSK | Save

First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial

Journal Article

Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
Lancet Oncology (2023)

Fulltext@MSK | Save

National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: Challenges and recommended priorities

Review

Kim, M. M.; Mehta, M. P.; Smart, D. K.; Steeg, P. S.; Hong, J. A.; Espey, M. G.; Prasanna, P. G.; Crandon, L.; Hodgdon, C.; Kozak, N.; more...
Lancet Oncology (2023)

Fulltext@MSK | Save

Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): A single-arm, multicentre, phase 2 trial

Journal Article

Albiges, L.; Gurney, H.; Atduev, V.; Suarez, C.; Climent, M. A.; Pook, D.; Tomczak, P.; Barthelemy, P.; Lee, J. L.; Stus, V.; more...
Lancet Oncology (2023)

Fulltext@MSK | Save

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): An international, single-arm, phase 2 study

Journal Article

Pant, S.; Schuler, M.; Iyer, G.; Witt, O.; Doi, T.; Qin, S.; Tabernero, J.; Reardon, D. A.; Massard, C.; Minchom, A.; more...
Lancet Oncology (2023)

Fulltext@MSK | Save

Spotlight: Preoperative chemoradiotherapy or perioperative chemotherapy for patients with gastro-oesophageal junction adenocarcinoma

Editorial

Ilson, D.
Lancet Oncology (2023)

Fulltext@MSK | Save